SR
Sarmistha Roy
About Sarmistha Roy
Data last updated:
Sarmistha Roy is a Director at James T Kent Homoeo Lab Private Limited (since 2002). The companies operate in Healthcare and Business Services. James T Kent Homoeo Lab Private Limited reported revenue of ₹1.33 Cr (FY 2025). Earlier, Sarmistha Roy was a Director at Jtk Herbs Private Limited (2018).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 James T Kent Homoeo Lab Private Limited U85193WB1997PTC086163 | Director | 16 Mar 2002 | 1997 | ₹1.33 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Jtk Herbs Private Limited U74999WB2018PTC226368 | Director | 31 May 2018 | 2018 | ₹16.1 Lakh (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Sarmistha Roy
| Name | DIN | Company | Designation |
|---|---|---|---|
| Tanuja Dutta | 05157667 | James T Kent Homoeo Lab Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sarmistha Roy
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sarmistha Roy
Sarmistha Roy currently holds 1 directorship: James T Kent Homoeo Lab Private Limited (Director, since 16 Mar 2002, revenue ₹1.33 Cr (FY 2025)).
Sarmistha Roy was first appointed on 16 Mar 2002 as Director at James T Kent Homoeo Lab Private Limited. The most recent appointment on record is 31 May 2018 at Jtk Herbs Private Limited.
Sarmistha Roy held 1 earlier board appointment: Jtk Herbs Private Limited (Director, 31 May 2018 to 05 Jul 2018).
The current boards of Sarmistha Roy's companies include Tanuja Dutta (James T Kent Homoeo Lab Private Limited).